The estimated Net Worth of Leaf Ventures Ii, L.P.New L... is at least $8.09 million dollars as of 21 November 2013. Leaf L owns over 365,000 units of MEI Pharma Inc stock worth over $5,075,035 and over the last 11 years Leaf sold MEIP stock worth over $3,011,250.
Leaf has made over 1 trades of the MEI Pharma Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Leaf sold 365,000 units of MEIP stock worth $3,011,250 on 21 November 2013.
The largest trade Leaf's ever made was selling 365,000 units of MEI Pharma Inc stock on 21 November 2013 worth over $3,011,250. On average, Leaf trades about 365,000 units every 0 days since 2013. As of 21 November 2013 Leaf still owns at least 1,680,475 units of MEI Pharma Inc stock.
You can see the complete history of Leaf L stock trades at the bottom of the page.
Over the last 12 years, insiders at MEI Pharma Inc have traded over $26,282,680 worth of MEI Pharma Inc stock and bought 597,450 units worth $2,541,200 . The most active insiders traders include Ventures Vii, Llc Vivo Vent..., Leaf Ventures Ii, L.P.New L... et Josiah T Austin. On average, MEI Pharma Inc executives and independent directors trade stock every 91 days with the average trade being worth of $360,383. The most recent stock trade was executed by Funds Management Lp Anson A... on 22 September 2023, trading 48,060 units of MEIP stock currently worth $329,211.
mei pharma (nasdaq: meip) is a san diego-based oncology company focused on the clinical development of novel therapies for cancer. our lead drug candidate is pracinostat, a potential best-in-class, oral hdac inhibitor that has been granted breakthrough therapy designation from the fda in combination with azacitidine for the treatment of patients with newly diagnosed aml who are ≥75 years of age or unfit for intensive chemotherapy. our pipeline of drug candidates also includes me-401 (formerly pwt143), a next-generation oral pi3k delta inhibitor, and me-344, a novel mitochondrial inhibitor. for more, please go to www.meipharma.com.
MEI Pharma Inc executives and other stock owners filed with the SEC include: